An expert in clinical diagnostics, Dr. Matthew J. Oberley joined Caris Life Sciences in 2019 and has held a series of leadership positions in laboratory management and technology deployment. As Senior Vice President, Chief Clinical Officer and Pathologist-in-Chief, he is responsible for clinical development strategy, patient safety, external stakeholder engagement and the management of laboratory-based clinical teams.
Dr. Oberley leads Caris’ growing Pathologist and Molecular Genetics group, which includes over 40 board-certified and sub-specialty trained pathologists and molecular geneticists. He recently oversaw the development, clinical validation and deployment of a high-capacity digital pathology system at Caris. This system generates over a petabyte of data from more than 1M slide scans per year and has significantly improved laboratory efficiency.
Dr. Oberley has coauthored over 150 journal articles, book chapters and abstracts in the areas of molecular biology and genetics, diagnostics and hematologic malignancies.
Prior to joining Caris, Dr. Oberley was on the faculty at the University of Southern California and served as Director of Hematopathology at Children’s Hospital Los Angeles. Dr. Oberley received his MD and PhD from the University of Wisconsin – Madison School of Medicine and Public Health and is board-certified in Anatomic, Clinical and Hematopathology.